triazoles has been researched along with Malignant Mesothelioma in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gen, S; Hashimoto, N; Hori, K; Kodama, Y; Matsubara, D; Morise, M; Sato, M; Sato, T; Sekido, Y; Tanaka, I | 1 |
| Colangelo, D; Osella, D; Zanellato, I | 1 |
| Alessandrini, G; Amoreo, CA; Blandino, G; Ciliberto, G; Cioce, M; De Maria, R; di Martino, S; Facciolo, F; Galati, R; Nuvoli, B; Pass, HI; Strano, S | 1 |
| Cominetti, D; De Cesare, M; Deraco, M; Doldi, V; Friedlander, S; Gandellini, P; Kauffman, MG; Landesman, Y; Lopergolo, A; Pennati, M; Shacham, S; Zaffaroni, N | 1 |
4 other study(ies) available for triazoles and Malignant Mesothelioma
| Article | Year |
|---|---|
Oxytocin receptor is a promising therapeutic target of malignant mesothelioma.
Topics: Animals; Biomarkers, Tumor; Cell Line, Tumor; Cell Proliferation; Female; Gene Knockdown Techniques; HEK293 Cells; Humans; Mesothelioma, Malignant; Mice; Mice, Inbred BALB C; Mice, Nude; Oxytocin; Pyridines; Receptors, Oxytocin; RNA, Messenger; Transfection; Treatment Outcome; Triazoles; Tumor Burden; Xenograft Model Antitumor Assays | 2021 |
JQ1, a BET Inhibitor, Synergizes with Cisplatin and Induces Apoptosis in Highly Chemoresistant Malignant Pleural Mesothelioma Cells.
Topics: A549 Cells; Antineoplastic Agents; Apoptosis; Azepines; beta-Galactosidase; Cell Cycle Checkpoints; Cell Cycle Proteins; Cellular Senescence; Cisplatin; DNA Breaks; Drug Resistance, Neoplasm; Drug Synergism; Drug Therapy, Combination; Humans; Lung Neoplasms; Mesothelioma; Mesothelioma, Malignant; Nuclear Proteins; Pleural Neoplasms; Proto-Oncogene Proteins c-fos; Proto-Oncogene Proteins c-myc; Transcription Factors; Transcription, Genetic; Triazoles | 2018 |
HSP90 inhibition alters the chemotherapy-driven rearrangement of the oncogenic secretome.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cellular Senescence; Cisplatin; Drug Resistance, Neoplasm; HSP90 Heat-Shock Proteins; Humans; Lung Neoplasms; Male; Mesothelioma; Mesothelioma, Malignant; Mice; Mice, Inbred NOD; Mice, SCID; Pemetrexed; Secretory Pathway; Triazoles | 2018 |
Anti-tumor activity of selective inhibitors of XPO1/CRM1-mediated nuclear export in diffuse malignant peritoneal mesothelioma: the role of survivin.
Topics: Acrylamides; Active Transport, Cell Nucleus; Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cyclin-Dependent Kinase Inhibitor p21; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Exportin 1 Protein; G1 Phase Cell Cycle Checkpoints; Humans; Hydrazines; Inhibitor of Apoptosis Proteins; Karyopherins; Lung Neoplasms; Mesothelioma; Mesothelioma, Malignant; Mice; Mice, SCID; Neoplasm Proteins; Oxadiazoles; Peritoneal Neoplasms; Real-Time Polymerase Chain Reaction; Receptors, Cytoplasmic and Nuclear; Survivin; Thiazoles; Triazoles; Tumor Suppressor Protein p53 | 2015 |